These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1695804)

  • 21. Evaluation of carcinoembryonic antigen and periodic acid-Schiff stains in the diagnosis of serous and mucinous ovarian tumors: morphometrical study.
    Aalto ML; Selkäinaho K; Collan Y
    Appl Pathol; 1986; 4(1-2):83-9. PubMed ID: 3034311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
    Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H
    Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
    Liu MP; Lu ZT; Chen W
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum level of the tumor marker CA 125 in ovarian pathology].
    Bagni B; Pansini FS; Feggi LM; Prandini N; Mollica G
    Radiol Med; 1987 Nov; 74(5):448-50. PubMed ID: 3479814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical demonstration of epithelial membrane antigen (EMA), carcinoembryonic antigen (CEA), and keratin on mammary and extramammary Paget's disease.
    Mori O; Hachisuka H; Sasai Y
    Acta Histochem; 1989; 85(1):93-100. PubMed ID: 2469278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.
    Devaney K; Goodman ZD; Ishak KG
    Am J Surg Pathol; 1994 Nov; 18(11):1078-91. PubMed ID: 7943529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion).
    Tavassoli FA
    Mod Pathol; 1988 Nov; 1(6):407-14. PubMed ID: 2464824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas.
    Ryuko K; Iwanari O; Kitao M; Moriwaki S
    Gynecol Oncol; 1993 May; 49(2):215-24. PubMed ID: 8504990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
    Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
    Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
    Crombach G; Zippel HH; Würz H
    Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-cell antigen marker expression in nasopharyngeal carcinoma.
    Zhong XY; Senba M; Gu JN; Itakura H
    Zentralbl Pathol; 1993 Nov; 139(4-5):281-6. PubMed ID: 7510513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synovial sarcoma. An immunohistochemical study of the epithelial component.
    Jørgensen LJ; Lyon H; Myhre-Jensen O; Nordentoft A; Sneppen O
    APMIS; 1994 Mar; 102(3):191-6. PubMed ID: 7514419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in expression of differentiation markers between normal ovarian cells and derived tumors.
    Van Niekerk CC; Ramaekers FC; Hanselaar AG; Aldeweireldt J; Poels LG
    Am J Pathol; 1993 Jan; 142(1):157-77. PubMed ID: 7678716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study.
    Nouwen EJ; Hendrix PG; Dauwe S; Eerdekens MW; De Broe ME
    Am J Pathol; 1987 Feb; 126(2):230-42. PubMed ID: 3548400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunoperoxidase localization of tumour markers in ovarian cancer: the value of CEA, EMA, cytokeratin and DD9.
    Hammond RH; Bates TD; Clarke DG; Grant AG; Haines AM; Eustace DL; Heyderman E
    Br J Obstet Gynaecol; 1991 Jan; 98(1):73-83. PubMed ID: 1705435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian tumors of low malignant potential (borderline tumors): immune morphology and current status.
    Neunteufel W; Gitsch G; Schieder K; Kölbl H; Breitenecker G
    Anticancer Res; 1989; 9(4):993-7. PubMed ID: 2684001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial cell markers and proliferating cells in odontogenic jaw cysts.
    Matthews JB; Mason GI; Browne RM
    J Pathol; 1988 Dec; 156(4):283-90. PubMed ID: 2465398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
    Rodabaugh KJ; Mhawech-Fauceglia P; Groth J; Lele S; Sood AK
    Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.